JPWO2022202816A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022202816A5 JPWO2022202816A5 JP2023509199A JP2023509199A JPWO2022202816A5 JP WO2022202816 A5 JPWO2022202816 A5 JP WO2022202816A5 JP 2023509199 A JP2023509199 A JP 2023509199A JP 2023509199 A JP2023509199 A JP 2023509199A JP WO2022202816 A5 JPWO2022202816 A5 JP WO2022202816A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- peptide
- peptide according
- pharmaceutical composition
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021047773 | 2021-03-22 | ||
| JP2021192510 | 2021-11-26 | ||
| PCT/JP2022/013180 WO2022202816A1 (ja) | 2021-03-22 | 2022-03-22 | ペプチド及びペプチドを含む組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022202816A1 JPWO2022202816A1 (https=) | 2022-09-29 |
| JPWO2022202816A5 true JPWO2022202816A5 (https=) | 2025-04-03 |
Family
ID=83395638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023509199A Pending JPWO2022202816A1 (https=) | 2021-03-22 | 2022-03-22 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240209027A1 (https=) |
| EP (1) | EP4317174A4 (https=) |
| JP (1) | JPWO2022202816A1 (https=) |
| KR (1) | KR20230170918A (https=) |
| AU (1) | AU2022242421A1 (https=) |
| BR (1) | BR112023019228A2 (https=) |
| CA (1) | CA3214455A1 (https=) |
| IL (1) | IL307225A (https=) |
| MX (1) | MX2023011194A (https=) |
| TW (1) | TW202304947A (https=) |
| WO (1) | WO2022202816A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023048151A1 (ja) * | 2021-09-22 | 2023-03-30 | 塩野義製薬株式会社 | ウイルス増殖阻害活性を有する環状ペプチド |
| US20250250299A1 (en) * | 2022-03-28 | 2025-08-07 | Bristol-Myers Squibb Company | Macrocyclic immunomodulators |
| CN116445523B (zh) * | 2023-04-10 | 2024-05-07 | 西北农林科技大学 | 一种小麦抗逆性基因TaBSL3与应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5525491A (en) | 1991-02-27 | 1996-06-11 | Creative Biomolecules, Inc. | Serine-rich peptide linkers |
| IL155812A0 (en) | 2000-12-07 | 2003-12-23 | Lilly Co Eli | Glp-1 fusion proteins |
| US8658604B2 (en) * | 2005-02-17 | 2014-02-25 | Polyphor Ltd | Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity |
| WO2007066627A1 (ja) | 2005-12-06 | 2007-06-14 | The University Of Tokyo | 多目的アシル化触媒とその用途 |
| JP5818237B2 (ja) | 2010-09-09 | 2015-11-18 | 国立大学法人 東京大学 | Ｎ−メチルアミノ酸およびその他の特殊アミノ酸を含む特殊ペプチド化合物ライブラリーの翻訳構築と活性種探索法 |
| US20160068835A1 (en) | 2013-01-30 | 2016-03-10 | Peptidream Inc. | Flexible display method |
| CN111349150B (zh) * | 2020-03-24 | 2021-02-09 | 北京中科微盾生物科技有限责任公司 | 一种抑制新型冠状病毒的多肽及其用途 |
| CN111471088B (zh) * | 2020-04-21 | 2021-02-09 | 北京中科微盾生物科技有限责任公司 | 一种抑制sars-cov-2感染的多肽、组合物及其用途 |
| CN111643656B (zh) * | 2020-05-14 | 2022-07-19 | 悦康药业集团股份有限公司 | 广谱冠状病毒膜融合抑制剂及其抗艾滋病病毒的应用 |
| CN111732637B (zh) * | 2020-05-25 | 2022-03-01 | 上海交通大学 | 抑制新型冠状病毒SARS-CoV-2感染宿主细胞的多肽及其应用 |
| CN111499692B (zh) * | 2020-06-16 | 2020-12-04 | 国家纳米科学中心 | 靶向新型冠状病毒covid-19的多肽及其应用 |
| CN112630444B (zh) * | 2020-12-11 | 2024-05-24 | 深圳碳云智肽药物科技有限公司 | 基于靶点蛋白的多肽筛选方法 |
-
2022
- 2022-03-22 WO PCT/JP2022/013180 patent/WO2022202816A1/ja not_active Ceased
- 2022-03-22 TW TW111110690A patent/TW202304947A/zh unknown
- 2022-03-22 AU AU2022242421A patent/AU2022242421A1/en active Pending
- 2022-03-22 IL IL307225A patent/IL307225A/en unknown
- 2022-03-22 JP JP2023509199A patent/JPWO2022202816A1/ja active Pending
- 2022-03-22 EP EP22775599.8A patent/EP4317174A4/en active Pending
- 2022-03-22 MX MX2023011194A patent/MX2023011194A/es unknown
- 2022-03-22 US US18/283,376 patent/US20240209027A1/en active Pending
- 2022-03-22 BR BR112023019228A patent/BR112023019228A2/pt not_active Application Discontinuation
- 2022-03-22 KR KR1020237035941A patent/KR20230170918A/ko active Pending
- 2022-03-22 CA CA3214455A patent/CA3214455A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2022202816A5 (https=) | ||
| CN114786659A (zh) | 用于治疗汉坦病毒感染的mek抑制剂 | |
| JP7386455B2 (ja) | 乾癬の治療薬 | |
| JP6145778B2 (ja) | 特発性炎症性筋疾患の予防又は治療剤 | |
| CN111542335A (zh) | 炎症性肠病的治疗药 | |
| DK1768689T3 (en) | Compositions and methods for treating cardiovascular disease | |
| BR112021002447A2 (pt) | peptídeos de penetração celular | |
| CN113747899A (zh) | 用于治疗乙型肝炎的Toll样受体激动剂 | |
| JP2015504088A (ja) | 肝疾患の治療 | |
| US20230149515A1 (en) | Inhibition of sars-cov-2 viral entry through oral administration of lactoferrin and uses thereof | |
| US11883410B2 (en) | Preventative and therapeutic agents for sarcopenia | |
| US20250177434A1 (en) | Antiviral agents for treatment of coronaviruses | |
| CN104853778A (zh) | 用于肌萎缩性侧索硬化的治疗剂 | |
| US20240180997A1 (en) | Peptide inhibitors of nf kappa b and use thereof in treatment of covid-19 and inflammatory diseases | |
| KR102451145B1 (ko) | 로틀레린을 유효성분으로 포함하는 바이러스 감염증의 예방 또는 치료용 약제학적 조성물 | |
| Lin et al. | Cardio‐respiratory and phenotypic rescue of dystrophin/utrophin‐deficient mice by combination therapy | |
| JP5686734B2 (ja) | Ｓｉｒｓまたは強毒性インフルエンザ感染症処置のための医薬組成物 | |
| US20220062247A1 (en) | Use of a par-1 antagonist for the treatment of a chronic inflammatory intestinal disease | |
| KR20230004569A (ko) | 항비만 펩티드 및 이의 용도 | |
| US10143666B2 (en) | Small molecule inhibitors targeting CAG-repeat RNA toxicity in polyglutamine diseases | |
| JP3499562B2 (ja) | Ｃｒｏｈｎ’ｓ病および／または潰瘍性大腸炎の治療もしくは予防 | |
| CN116655773B (zh) | 一种肽类激素Elabela突变体及其在心肾综合征中的应用 | |
| TW202021610A (zh) | 短胜肽用於治療/預防高血壓及其相關疾病之用途 | |
| JP2024020797A (ja) | 筋萎縮の治療剤 | |
| Kogaki et al. | Efficacy and Safety of Sildenafil in Japanese Pediatric Patients with Pulmonary Arterial Hypertension |